The Abstract: July 25, 2022
July 25, 2022 Gillings researchers are recognized for work in pharmacoepidemiology, public health leadership and marine environmental sciences, and a recent alumnus receives outstanding dissertation honors.
Immune modulator drugs improved survival for people hospitalized with COVID-19
July 15, 2022 A clinical trial led by the NIH, with support from the Duke Clinical Research Institute and the Gillings School, recently showed that using infliximab or abatacept to treat adults hospitalized with COVID-19 did not shorten recovery time but did improve survival rates.
Preventative therapy for malaria has positive effect on baby birth weight, unless intestinal pathogens are present
June 29, 2022 Recently published in eBioMedicine, this study represents work that originated with the late Gillings School professor Dr. Steve Meshnick.
Removing Medicaid prescription restrictions could improve treatment for opioid use disorder
June 24, 2022 Removing the Medicaid requirement for prior approval to fill prescriptions for buprenorphine, a common treatment for opioid use disorder, could lead to more patients gaining access to this life-saving medication.
Weber publishes 50th paper about coronaviruses and COVID-19
June 23, 2022 Infectious disease expert Dr. David Weber has reached a formidable hallmark: his 50th publication about coronaviruses and COVID-19. His research has played an important role in creating new policies and ways that we can keep ourselves and patients safe in community and hospital settings.
Grant explores little-understood effects of wildfire smoke
June 16, 2022 A new study from recent MPH@UNC graduate Emilly Grant assesses what scientists currently know about the long-term health effects of wildfire exposure – and what they don’t. Her findings underscore an urgent need for greater scrutiny of these health impacts in the face of growing risk from devastating wildfires that are increasing in frequency.
The missing diversity in human epigenomic studies
June 9, 2022 Researchers discuss the lack of diversity in epigenomic studies, which undermines scientists’ ability to understand the causes and risks of disease in different groups of people.
Researchers develop app to detect neglected tropical disease affecting millions of people worldwide
June 2, 2022 The new technology is estimated to detect cases of trachomatous trichiasis with 92% accuracy.
Gaps in screening leave many NC children at risk of lead exposure
June 1, 2022 Exposure to lead can be harmful to a child's development. A new study led by Gillings School alumna Dr. Elizabeth Kamai suggests that North Carolina's current high-risk screening practices may fail to identify thousands of children with elevated blood lead levels.
Researchers evaluate diagnostic testing landscape for tick-borne disease in the Southeast
May 25, 2022 Tick-borne disease and Lyme are not synonymous, especially in North Carolina. If anything, other pathogens like rickettsia and ehrlichia are much more common, and testing should reflect that, researchers say.
